Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • iGluR
    (2)
  • Autophagy
    (1)
  • Raf
    (1)
  • Sodium Channel
    (1)
  • p38 MAPK
    (1)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Nervous System
    (1)
Filter
Search Result
Results for "

remacemide

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • Remacemide
    T71969128298-28-2
    Remacemide is a low-affinity NMDA antagonist with sodium channel blocking properties. It has been studied for the treatment of acute ischemic stroke, epilepsy, Huntington's disease, and Parkinson's disease.
    • $1,520
    6-8 weeks
    Size
    QTY
  • Doramapimod HCl
    T710581283526-53-3
    Doramapimod HCl is the salt form of Doramapimod, a member of the N-pyrazole-N'-naphthly urea class of p38MAPK inhibitors, which binds to the kinase with both slow association and dissociation rates. BIRB -796 has entered clinical trials for the treatment of autoimmune diseases.
    • $1,520
    1-2 weeks
    Size
    QTY
  • Remacemide hydrochloride
    T23231111686-79-4
    Remacemide hydrochloride is a NMDA receptor antagonist.
    • $1,520
    6-8 weeks
    Size
    QTY
  • 1,2-diphenylpropan-2-amine
    T50052118910-28-4
    1,2-Diphenylpropan-2-amine is the monohydrochloride metabolite of the (S,R)-isomer of Remacemide.1,2-Diphenylpropan-2-amine has anticonvulsant properties.
    • $32
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale